The IIL portfolio contains independent opportunities at different stages of technical, commercial and regulatory maturity. Public descriptions are deliberately limited. A project being listed does not mean that every claim has been validated, that regulatory approval has been obtained or that an investment is available to every person.
Selected project categories
Non-confidential overview
Additive Manufacturing Competence Centre
The competence-centre concept combines equipment, central expertise, methods, training, documentation and an operating model.
Review opportunityNon-confidential overview
Advanced Fire-Protection Materials
The opportunity concerns advanced fire-protection materials and application know-how subject to performance, certification and manufacturing diligence.
Review opportunityNon-confidential overview
AI Cardiology Technology Opportunity
AI-supported cardiology may improve analysis or workflow, but value depends on data quality, validation, integration and accountable clinical use.
Review opportunityNon-confidential overview
Artificial Blood and Blood-Substitute Technology
This is an investigational life-science opportunity; public information must not be interpreted as evidence of safety, efficacy or approval.
Review opportunityNon-confidential overview
Artificial Skin and Advanced Wound-Care Opportunity
The opportunity concerns technologies intended to support wound protection, tissue management and advanced care pathways.
Review opportunityNon-confidential overview
Biosignal and Bioresonance Technology Opportunity
Claims in this field require particularly careful scientific and regulatory scrutiny. Public description indicates an area of investigation, not validated diagnosis or treatment.
Review opportunityNon-confidential overview
Healthcare AI Commercialisation Portfolio
A portfolio view can reveal reusable data, validation and deployment capability, but each use case needs its own intended use and evidence.
Review opportunityNon-confidential overview
Lipid Delivery Platform for Medicines and Nutrients
The IIL-managed concept uses lipid-based carriers for medicines, vitamins, minerals or other active substances and is described publicly only at category level.
Review opportunityNon-confidential overview
MaviVital Multisensory Medical Monitor
MaviVital is presented as a multisensory medical-monitor opportunity subject to detailed technical, regulatory and commercial diligence.
Review opportunityNon-confidential overview
Medical-Device Manufacturing Transfer
A medical-device manufacturing transfer requires design control, supplier control, validated process, quality agreements and regulatory responsibility.
Review opportunityNon-confidential overview
Waste-to-Energy Technology Opportunity
A waste-to-energy technology must be evaluated as a site-specific technical, environmental and commercial system.
Review opportunityNon-confidential overview
Wave-Based Oncology Research Technology
This is a research-stage oncology concept. Nothing on the public page is a treatment claim or substitute for established cancer care.
Review opportunityControlled disclosure
Public: problem, technology category, intended value, high-level maturity and potential route. Qualified: structured commercial and technical context. Controlled: detailed IP, evidence, regulatory, manufacturing and financial materials after the appropriate documentation.